Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in miceLactadherin promotes VEGF-dependent neovascularizationFrench Intensive Care Society, International congress - Réanimation 2016Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferationProteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques.B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells.Bone marrow transplantation reveals the in vivo expression of the mitochondrial uncoupling protein 2 in immune and nonimmune cells during inflammation.B cell depletion reduces the development of atherosclerosis in mice.Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.Cytokines in atherosclerosis: pathogenic and regulatory pathways.Age-related phenotypes in the staggerer mouse expand the RORalpha nuclear receptor's role beyond the cerebellum.Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in miceDefective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.Mechanisms of blood flow-induced vascular enlargement.The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives.Cellular mechanics and gene expression in blood vessels.Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease.The "CholesteROR" protective pathway in the vascular system.Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).Evidence of a role for lactadherin in Alzheimer's diseaseImmunomodulation to combat atherosclerosis: the potential role of immune regulatory cells.Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1Regulatory T cell responses: potential role in the control of atherosclerosis.The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by NO synthase inhibition by N-nitro-L-arginine methyl ester.Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemiaMFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injuryRegulatory T-cell immunity in atherosclerosis.Cytokines as regulators of atherosclerosis in murine models.Post-ischaemic neovascularization and inflammation.Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.Endothelial microparticles in diseases.
P50
Q28115933-FD8A5D89-26BC-4B9C-B3E6-74962165D16DQ28245534-E4688B8C-9AE9-4CF6-9D4D-FAFBC6A0EAB7Q28550357-C7D1136F-5088-48E2-9025-BBE73D378DDBQ30846013-44A7EEFF-E46F-409C-975B-EF9D3E0B44B0Q33212030-9059A2D8-FE6A-4F93-9955-B00C2468A383Q33518352-BE15B009-2FE4-4DF9-A14F-BDC2A6F970A4Q33520612-555039AB-B74A-4A58-84C6-B74133FB5CC6Q33704093-B24E21F7-A927-4E68-A588-5763A400D08DQ33736775-42A5781D-F1AB-4F33-A918-604F9F71A6ECQ33829848-D81A8D93-C14A-4399-9B06-F21F53B8D542Q33967659-074A2690-B532-4542-8D20-ED52576E8FFEQ34044387-DEFFDDF7-EE98-42A2-B558-3BF070C5D73CQ34151396-445DF077-6D2F-4105-BDA7-8030844CD1CFQ34455926-601C6915-6E19-41F7-9CB0-945608AE658BQ34469009-7763CE91-27CD-4572-9669-954DAFA9DF41Q34478873-FA8C629A-E0B1-40EE-8069-AFCA69766783Q34511711-CB3D58FB-C660-4129-BFA1-6885B36DB03FQ34535184-1A269FBF-880D-4AB1-9986-A37E16A2D63EQ34572318-B02A5BC9-EA6B-4100-BFC1-256115F6189FQ34661745-3723416E-D1F4-41A5-B212-C12B11D48D4EQ34745179-34172DDD-732D-43DD-B25E-61731CD47306Q34916098-7DB052E6-B07C-44B5-8AFD-847CBB73C1ADQ35106977-33A94684-D217-42CD-AFDD-154ECF2D2454Q35212898-74D3EDE6-7A58-459B-B94B-5AEB3503B545Q35627513-24EC5639-3B76-4360-B594-500E7BB065C6Q35642990-8D0A6474-8333-4781-89F7-7DA456451A79Q35748267-76F40D0E-5914-497C-8266-76BE7CF30F4EQ35781353-5DE95708-7296-4304-A290-3CDD61716DA3Q35873748-90B340DE-B59D-4A2C-97A0-3AC13615D173Q36095677-CD984E29-3F59-4838-90B2-4A6606E58F3DQ36251705-52EA5457-FE81-46A7-A486-0A8493E99A65Q36482278-2FAAFEC2-51D8-4916-A902-BEEE675D37F0Q36519690-1E6D7765-6C08-4949-AB5B-4EF5AF073B8FQ36520326-02027CB9-2EFC-4303-A780-0A33BFE98136Q36638155-DE88E3F2-F59E-4344-AAD5-AA5174270F92Q36812076-ED910D5C-CEA7-433B-8E05-77A7A74687C3Q37065929-7633825D-93A4-448D-BFF9-31D1A51EDA35Q37077934-152E42A7-3847-4456-BC32-89707917B1F7Q37303915-A499E6DB-3D48-4B74-A008-8FBD06E5C85EQ37319478-1453B413-8559-48DD-99E3-44B5B3D0CA70
P50
description
moleculair bioloog
@nl
name
Alain Tedgui
@ast
Alain Tedgui
@en
Alain Tedgui
@es
Alain Tedgui
@fr
Alain Tedgui
@nl
type
label
Alain Tedgui
@ast
Alain Tedgui
@en
Alain Tedgui
@es
Alain Tedgui
@fr
Alain Tedgui
@nl
prefLabel
Alain Tedgui
@ast
Alain Tedgui
@en
Alain Tedgui
@es
Alain Tedgui
@fr
Alain Tedgui
@nl
P1006
P214
P244
P268
P269
P1006
P19
P2038
Alain_Tedgui
P21
P213
0000 0000 3232 1280
P214
P244
P268
P269
P31
P569
1953-06-04T00:00:00Z
P735
P7859
lccn-n98803262